Substack · BioEquity Watch
Nuvation Bio ($NUVB) : The bane of rare cancers?
Rating: BULLISH | Target Price: $10.91 | Current Price: $6.10 | Implied Change: +78.85%
Since publication NUVB −22.9% α −23.3 pp vs S&P 500 · USD
US · 1 entry · 1 publication
NUVB
Nuvation Bio Inc.
- Entries
- 1
- Bullish
- 0
- Bearish
- 0
- First
- Sep 18, 2026
- Latest
- Sep 18, 2026
No entry states a stance.
Jan 25 – Oct 26 · per month
Full performance tracking Pro · free during launch
Alpha of every thesis on NUVB at 1, 3 and 6 months and since publication, and the full chart vs its benchmark.Free during launch: log in or sign up with your email to see it.
Sign up freeTimeline
Newest to oldest- September 2026 1 entry
Prices as of the Oct 27, 2026 close. Past performance does not guarantee future results. Price-only, excluding dividends, in local currency. Data may be delayed or inaccurate. Not investment advice. How it is calculated.